However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

The president has said the law is unfair to U.S. businesses. But lawyers say weakening it could end up costing corporate ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

The three-day-long 16th Asia Pharma Expo'-2025 kicked off at the Bangladesh-China Friendship Exhibition Center in Purbachal New Town today (12 February). The Bangladesh Association of Pharmaceutical ...

Revenue decreased by 37.41% YoY & profit decreased by 37.47% YoY, profit at ₹133 crore and revenue at ₹474.8 crore.

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q2 earnings. Here is a breakdown of the information Inmed ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

As the father of an 18-year-old girl who died from a single OxyContin pill in 2006 and as a creditor in the Purdue Pharma bankruptcy ... in Illinois Attorney General Kwame Raoul’s apparent ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a ...